Adesola AA, Cozma MA, Chen YF, Srichawla BS, Găman MA. Risk of hepatitis B reactivation in patients with myeloproliferative neoplasms treated with ruxolitinib. World J Hepatol 2023; 15(11): 1188-1195 [PMID: 38075009 DOI: 10.4254/wjh.v15.i11.1188]
Please LOGIN to submit a new comment.